Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michiel Coppens

Showing results (91-100 of 143) with videos related to

Pageof 15
Sort By:
Research and Practice in Thrombosis and Haemostasis|August 21, 2024
Primary postpartum hemorrhage in women with von Willebrand disease and carriers of hemophilia: a retrospective analysisMarieke Punt, Fe van Leusden, Kitty Bloemenkamp, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|August 6, 2024
An Intestinal Microbiome Intervention Affects Biochemical Disease Activity in Patients with Antiphospholipid SyndromeValérie L B I Jansen, Dagmar J M van Mourik, Mark Davids, et al.
Blood Advances|December 22, 2020
Intracranial hemorrhage with direct oral anticoagulants in patients with brain metastasesAvi Leader, Eva N Hamulyák, Brian J Carney, et al.
Journal of Thrombosis and Haemostasis : JTH|May 6, 2020
Incidence of venous thromboembolism in hospitalized patients with COVID-19Saskia Middeldorp, Michiel Coppens, Thijs F van Haaps, et al.
Blood Advances|May 17, 2023
American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testingSaskia Middeldorp, Robby Nieuwlaat, Lisa Baumann Kreuziger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 19, 2021
Similar sports participation as the general population in Dutch persons with haemophilia; results from a nationwide studyOlav Versloot, Erna C van Balen, Shermarke Hassan, et al.
European Journal of Internal Medicine|August 23, 2020
ETNA VTE Europe: A contemporary snapshot of patients treated with edoxaban in clinical practice across eight European countriesAlexander T Cohen, Ulrich Hoffmann, Philippe Hainaut, et al.
American Journal of Hematology|May 1, 2019
BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand diseaseFerdows Atiq, Karin Fijnvandraat, Karin P M van Galen, et al.
Research and Practice in Thrombosis and Haemostasis|February 27, 2026
Etranacogene dezaparvovec in people with hemophilia B with preexisting adeno-associated virus 5 neutralizing antibodies: 4-year subgroup results from the HOPE-B trialRobert Klamroth, Paul E Monahan, Paul Van der Valk, et al.
Circulation|February 21, 2023
Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa InhibitorsTruman J Milling, Saskia Middeldorp, Lizhen Xu, et al.
Pageof 15

Showing results (91-100 of 143) with videos related to

Sort By:
Pageof 15
Research and Practice in Thrombosis and Haemostasis|August 21, 2024
Primary postpartum hemorrhage in women with von Willebrand disease and carriers of hemophilia: a retrospective analysisMarieke Punt, Fe van Leusden, Kitty Bloemenkamp, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|August 6, 2024
An Intestinal Microbiome Intervention Affects Biochemical Disease Activity in Patients with Antiphospholipid SyndromeValérie L B I Jansen, Dagmar J M van Mourik, Mark Davids, et al.
Blood Advances|December 22, 2020
Intracranial hemorrhage with direct oral anticoagulants in patients with brain metastasesAvi Leader, Eva N Hamulyák, Brian J Carney, et al.
Journal of Thrombosis and Haemostasis : JTH|May 6, 2020
Incidence of venous thromboembolism in hospitalized patients with COVID-19Saskia Middeldorp, Michiel Coppens, Thijs F van Haaps, et al.
Blood Advances|May 17, 2023
American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testingSaskia Middeldorp, Robby Nieuwlaat, Lisa Baumann Kreuziger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 19, 2021
Similar sports participation as the general population in Dutch persons with haemophilia; results from a nationwide studyOlav Versloot, Erna C van Balen, Shermarke Hassan, et al.
European Journal of Internal Medicine|August 23, 2020
ETNA VTE Europe: A contemporary snapshot of patients treated with edoxaban in clinical practice across eight European countriesAlexander T Cohen, Ulrich Hoffmann, Philippe Hainaut, et al.
American Journal of Hematology|May 1, 2019
BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand diseaseFerdows Atiq, Karin Fijnvandraat, Karin P M van Galen, et al.
Research and Practice in Thrombosis and Haemostasis|February 27, 2026
Etranacogene dezaparvovec in people with hemophilia B with preexisting adeno-associated virus 5 neutralizing antibodies: 4-year subgroup results from the HOPE-B trialRobert Klamroth, Paul E Monahan, Paul Van der Valk, et al.
Circulation|February 21, 2023
Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa InhibitorsTruman J Milling, Saskia Middeldorp, Lizhen Xu, et al.
Pageof 15